We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Skin Autofluorescence Detects Heart Disease and Diabetes

By HospiMedica International staff writers
Posted on 17 Dec 2018
Print article
Image: The AGE reader used in the study (Photo courtesy of Diagnoptics Technologies).
Image: The AGE reader used in the study (Photo courtesy of Diagnoptics Technologies).
Non-invasive skin autofluorescence can predict type 2 diabetes (T2D), cardiovascular disease (CVD), and mortality in the general population, according to a new study.

Researchers at University Medical Center Groningen (UMCG; The Netherlands), Medical Center Leeuwarden (The Netherlands), and other institutions conducted a prospective analysis study to examine if the measurement of skin autofluorescence can predict risk of incident T2D, CVD, and mortality. The study included 72,880 participants of the Dutch Lifelines Cohort Study, who underwent baseline investigations between 2007-2013, had validated baseline skin autofluorescence values available, and were not known to have T2D or CVD.

The results revealed that after a median follow-up of four years, 1.4% of participants developed T2D, 1.7% were diagnosed with CVD, and 1.3% had died. Baseline skin autofluorescence was elevated in all three groups, compared with those who lived and remained free of the two diseases. The researchers also found that skin autofluorescence predicted development of T2D, CVD and mortality independently of traditional risk factors, such as the metabolic syndrome, blood glucose, and HbA1c. The study was published on November 21, 2018, in Diabetologia.

“Both previous and present findings support the clinical utility of skin autofluorescence as a first screening method for type two diabetes, cardiovascular disease, and mortality,” concluded lead author Robert van Waateringe, MD, of UMCG, and colleagues. “The quick, noninvasive, measurement of skin autofluorescence may even allow use in nonmedical settings or public locations such as supermarkets, pharmacies, or drug stores as a first estimate of risk.”

Skin autofluorescence is a noninvasive method of assessing the accumulation of advanced glycation end products (AGEs) with fluorescent properties in dermal tissue. AGEs are formed in a multistep process by glycation and oxidation of free amino groups of proteins, lipids, and nucleic acids. They can cause an increase in vascular stiffness and elevated blood pressure, accelerate the progression of atherosclerosis, and may also worsen hyperglycemia by increasing inflammation and oxidative stress in beta cells. Skin autofluorescence increases with ageing, is elevated in people with T2D, as well as with the individual components of metabolic syndrome.

Related Links:
University Medical Center Groningen
Medical Center Leeuwarden

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
EEG System
BRAIN QUICK

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.